Skip to main content
. 2013 May 9;1(4):780–784. doi: 10.3892/mco.2013.112

Figure 2.

Figure 2.

Five-year overall survival rate and adjuvant treatment. Among patients not receiving adjuvant treatment, those with adenocarcinoma (AC) exhibited a similar outcome to those with squamous cell carcinoma (SCC) (93.1 vs. 94.0%, respectively; P=0.9497). By contrast, among patients who underwent adjuvant treatment following radical hysterectomy, those with AC had a significantly worse outcome compared to those with SCC (73.7 vs. 83.1%, respectively; P=0.0368).